Development and effectiveness validation of the ICF-COVID combination scale
Jue Li, M.M1, Lin Chen, M.D1, Wei Ren, M.M1, Min Wen, MBBS2, Shouguo Liu, M.D3, Hai Li, M.D1, Jianan Li , M.D3# and Wenzhi Cai, M.D1#
1Department of nursing, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, People’s Republic of China
2Department of nursing, The Third People’s Hospital of Shenzhen, Guangdong, People’s Republic of China
3Department of Rehabilitation Medicine, The First Affiliated Hospital With Nanjing Medical University, Jiangsu, Nanjing , People’s Republic of China
Objective: To develop an ICF-COVID scale and evaluate its reliability and validity. By establishing such a scale, we hope to provide clinical advices for the rehabilitation of suspected patients with new covavirus pneumonia.
Design：Firstly, literature review and expert group-discussion were applied to determine the initial items of the ICF-COVID scale. Secondly, the ICF-COVID scale was applied in 155 suspected patients with new coronary pneumonia by online survey. Finally, the reliability and validity of the scale were evaluated.
Setting: A face-to-face offline research but in an electronic survey manner.
Perticipants: 155 suspected patients with new coronary pneumonia from ten hospitals.
Interventions: Not applicable.
Main Outcome Measures: Cronbach α coefficient, Spearman-Brown half-reliability coefficient, KMO value, S-CVI value and I-CVI value.
Results: The ICF-COVID scale contains five items. The Cronbach α coefficient of the scale was 0.861. Spearman-Brown half- reliability coefficient was 0.814. KMO value was 0.854. S-CVI value was 0.813, and I-CVI value was between 0.846 and 1.000.
Conclusion: The ICF-COVID scale had a good reliability and validity. It can evaluate the health and function status of patients with new coronary pneumonia.
new coronary pneumonia; ICF; ICF generic set; functional evaluation; reliability; validity